Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery.

about

Targeted nanosystems: Advances in targeted dendrimers for cancer therapy The new era of nanotechnology, an alternative to change cancer treatment.

P2860

Q36679983-A61105B9-4089-4446-BA4B-6C182238F2A9 Q42370576-CC1F1069-E7D0-485A-BAEB-59629705591D

P2860

Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery.

Item

http://www.wikidata.org/entity/Q36024654

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Enzyme-responsive doxorubicin ...... for anticancer drug delivery.

@ast

Enzyme-responsive doxorubicin ...... for anticancer drug delivery.

@en

type

Item

label

Enzyme-responsive doxorubicin ...... for anticancer drug delivery.

@ast

Enzyme-responsive doxorubicin ...... for anticancer drug delivery.

@en

prefLabel

Enzyme-responsive doxorubicin ...... for anticancer drug delivery.

@ast

Enzyme-responsive doxorubicin ...... for anticancer drug delivery.

@en

P1476

Enzyme-responsive doxorubicin ...... for anticancer drug delivery.

@en

P2093

Dae Hwan Kang

http://www.w3.org/2001/XMLSchema#string

Hyun Chul Lee

http://www.w3.org/2001/XMLSchema#string

Hyung-Kyu Park

http://www.w3.org/2001/XMLSchema#string

Jong-Suk Oh

http://www.w3.org/2001/XMLSchema#string

Sam-Gyu Lee

http://www.w3.org/2001/XMLSchema#string

Sang Joon Lee

http://www.w3.org/2001/XMLSchema#string

Young-Il Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review

Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery

RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.

Dendrimers: synthesis, applications, and properties.

Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.

EPR: Evidence and fallacy.

Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.

Synthesis of a novel polyamidoamine dendrimer conjugating with alkali blue as a lymphatic tracer and study on the lymphatic targeting in vivo.

Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate.

P304

5489-5503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S87145

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26357473

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

nanoparticle

P932

4559238

http://www.w3.org/2001/XMLSchema#string

Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery.

about

P2860

P2860

Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932